These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 25573156)

  • 1. Acetate supplementation as a means of inducing glioblastoma stem-like cell growth arrest.
    Long PM; Tighe SW; Driscoll HE; Fortner KA; Viapiano MS; Jaworski DM
    J Cell Physiol; 2015 Aug; 230(8):1929-43. PubMed ID: 25573156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triacetin-based acetate supplementation as a chemotherapeutic adjuvant therapy in glioma.
    Tsen AR; Long PM; Driscoll HE; Davies MT; Teasdale BA; Penar PL; Pendlebury WW; Spees JL; Lawler SE; Viapiano MS; Jaworski DM
    Int J Cancer; 2014 Mar; 134(6):1300-10. PubMed ID: 23996800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetate supplementation induces growth arrest of NG2/PDGFRα-positive oligodendroglioma-derived tumor-initiating cells.
    Long PM; Tighe SW; Driscoll HE; Moffett JR; Namboodiri AM; Viapiano MS; Lawler SE; Jaworski DM
    PLoS One; 2013; 8(11):e80714. PubMed ID: 24278309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-acetylaspartate (NAA) and N-acetylaspartylglutamate (NAAG) promote growth and inhibit differentiation of glioma stem-like cells.
    Long PM; Moffett JR; Namboodiri AMA; Viapiano MS; Lawler SE; Jaworski DM
    J Biol Chem; 2013 Sep; 288(36):26188-26200. PubMed ID: 23884408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
    Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
    Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
    Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
    Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-elemene inhibits stemness, promotes differentiation and impairs chemoresistance to temozolomide in glioblastoma stem-like cells.
    Zhu TZ; Li XM; Luo LH; Song ZQ; Gao X; Li ZQ; Su JY; Liang GB
    Int J Oncol; 2014 Aug; 45(2):699-709. PubMed ID: 24841897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomestatin impairs glioma stem cell survival and growth through the disruption of telomeric G-quadruplex and inhibition of the proto-oncogene, c-Myb.
    Miyazaki T; Pan Y; Joshi K; Purohit D; Hu B; Demir H; Mazumder S; Okabe S; Yamori T; Viapiano M; Shin-ya K; Seimiya H; Nakano I
    Clin Cancer Res; 2012 Mar; 18(5):1268-80. PubMed ID: 22230766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
    Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
    Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoids promote a glioma stem cell-like phenotype and resistance to chemotherapy in human glioblastoma primary cells: Biological and prognostic significance.
    Kostopoulou ON; Mohammad AA; Bartek J; Winter J; Jung M; Stragliotto G; Söderberg-Nauclér C; Landázuri N
    Int J Cancer; 2018 Mar; 142(6):1266-1276. PubMed ID: 29067692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atracurium Besylate and other neuromuscular blocking agents promote astroglial differentiation and deplete glioblastoma stem cells.
    Spina R; Voss DM; Asnaghi L; Sloan A; Bar EE
    Oncotarget; 2016 Jan; 7(1):459-72. PubMed ID: 26575950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Verteporfin inhibits oxidative phosphorylation and induces cell death specifically in glioma stem cells.
    Kuramoto K; Yamamoto M; Suzuki S; Sanomachi T; Togashi K; Seino S; Kitanaka C; Okada M
    FEBS J; 2020 May; 287(10):2023-2036. PubMed ID: 31868973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.
    Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH
    Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cell signature in glioblastoma: therapeutic development for a moving target.
    Nakano I
    J Neurosurg; 2015 Feb; 122(2):324-30. PubMed ID: 25397368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin decreases malignant characteristics of glioblastoma stem cells via induction of reactive oxygen species.
    Gersey ZC; Rodriguez GA; Barbarite E; Sanchez A; Walters WM; Ohaeto KC; Komotar RJ; Graham RM
    BMC Cancer; 2017 Feb; 17(1):99. PubMed ID: 28160777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repurposing FDA approved drugs inhibiting mitochondrial function for targeting glioma-stem like cells.
    Datta S; Sears T; Cortopassi G; Woolard K; Angelastro JM
    Biomed Pharmacother; 2021 Jan; 133():111058. PubMed ID: 33378970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress toward acetate supplementation therapy for Canavan disease: glyceryl triacetate administration increases acetate, but not N-acetylaspartate, levels in brain.
    Mathew R; Arun P; Madhavarao CN; Moffett JR; Namboodiri MA
    J Pharmacol Exp Ther; 2005 Oct; 315(1):297-303. PubMed ID: 16002461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting atypical protein kinase C iota reduces viability in glioblastoma stem-like cells via a notch signaling mechanism.
    Phillips E; Lang V; Bohlen J; Bethke F; Puccio L; Tichy D; Herold-Mende C; Hielscher T; Lichter P; Goidts V
    Int J Cancer; 2016 Oct; 139(8):1776-87. PubMed ID: 27299852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of transforming growth factor-β signaling enhances oncolytic herpes simplex virus efficacy in patient-derived recurrent glioblastoma models.
    Esaki S; Nigim F; Moon E; Luk S; Kiyokawa J; Curry W; Cahill DP; Chi AS; Iafrate AJ; Martuza RL; Rabkin SD; Wakimoto H
    Int J Cancer; 2017 Dec; 141(11):2348-2358. PubMed ID: 28801914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-neoplastic activity of low-dose endothelial-monocyte activating polypeptide-II results from defective autophagy and G2/M arrest mediated by PI3K/Akt/FoxO1 axis in human glioblastoma stem cells.
    Liu J; Liu L; Xue Y; Meng F; Li S; Wang P; Liu Y
    Biochem Pharmacol; 2014 Jun; 89(4):477-89. PubMed ID: 24792437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.